BCAL Diagnostics Limited (ASX:BDX)
Australia flag Australia · Delayed Price · Currency is AUD
0.1200
+0.0050 (4.35%)
Feb 5, 2026, 10:44 AM AEST

BCAL Diagnostics Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
4.526.473.175.573.41
Short-Term Investments
---4-
Cash & Short-Term Investments
4.526.473.179.573.41
Cash Growth
-30.13%103.93%-66.84%180.88%718.69%
Other Receivables
2.592.782.690.790.35
Receivables
2.592.782.690.790.35
Prepaid Expenses
0.080.080.340.090.24
Other Current Assets
----0.13
Total Current Assets
7.29.346.210.464.13
Property, Plant & Equipment
2.72.892.170.140
Other Intangible Assets
0.020.04---
Total Assets
9.9112.278.3710.594.13
Accounts Payable
0.550.741.580.280.25
Accrued Expenses
0.590.950.480.630.26
Short-Term Debt
1.3----
Current Portion of Long-Term Debt
0.270.24---
Current Portion of Leases
0.220.20.16--
Other Current Liabilities
0.170.460.040.050.01
Total Current Liabilities
3.112.62.260.950.53
Long-Term Debt
0.120.4---
Long-Term Leases
0.460.680.9--
Other Long-Term Liabilities
--0--
Total Liabilities
3.693.683.160.950.53
Common Stock
33.8328.919.2818.879.46
Retained Earnings
-28.08-20.98-14.61-9.55-6.17
Comprehensive Income & Other
0.470.670.550.320.32
Shareholders' Equity
6.228.595.219.643.61
Total Liabilities & Equity
9.9112.278.3710.594.13
Total Debt
2.381.521.06--
Net Cash (Debt)
2.144.952.119.573.41
Net Cash Growth
-56.68%134.25%-77.93%180.88%2831.95%
Net Cash Per Share
0.010.020.010.050.03
Filing Date Shares Outstanding
365.97357.79243.09211.44206.88
Total Common Shares Outstanding
365.97314.29212.31207.44160
Working Capital
4.096.743.949.53.6
Book Value Per Share
0.020.030.020.050.02
Tangible Book Value
6.28.555.219.643.61
Tangible Book Value Per Share
0.020.030.020.050.02
Machinery
3.242.481.20.210.06
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.